| Date | Time | Place | EventName | Major Sponsor | Speakers | EventType |
12/13/2011
|
845 - 1700
|
San Diego: La Jolla Embassy Suites
|
Human Mass Balance and Metabolite Profiling Studies: Fundamentals, Applications and Case Studies
|
(1)Quotient Bioresearch
|
Chandra Prakash (Biogen), Bernard Murray (Gilead), Evan Smith (Pfizer), Ben Shen (Genentech)
|
Workshop
|
12/12/2011
|
845 - 1700
|
SF Bay Area: Foster City Crowne Plaza
|
Human Mass Balance and Metabolite Profiling Studies: Fundamentals, Applications and Case Studies
|
(2)Vitalea Science; XenoBiotic Laboratories, Inc.
|
Chandra Prakash (Biogen), Bernard Murray (Gilead), Evan Smith (Pfizer), Ben Shen (Genentech)
|
Workshop
|
12/2/2011
|
1100 - 1330
|
SF Bay Area: Foster City Crowne Plaza
|
PK/PD modeling and simulation: application in discovery through development (A joint meeting with Bay Area PK/PD Network)
|
(1)Bay Bioanalytical Laboratory, Inc.
|
Mike Eldon (Nektar Therapeutics)
|
Seminar luncheon
|
11/11/2011
|
1245 - 1730
|
SF Bay Area: Foster City Crowne Plaza
|
Product Development Strategy and Regulatory Perspective for Controlling Genotoxic Impurities
|
|
Mark Powley (FDA), Bo Shen (Amgen), Sophie Wang (Amgen), Christine Gu (Genentech), Larry Wigman (Genentech)
|
Workshop
|
11/4/2011
|
1100 - 1330
|
San Diego Area: Embassy Suites La Jolla
|
Use of high-resolution mass spectrometry as a single LC/MS platform in DMPK studies: Current applications and future directions
|
(1)AB SCIEX
|
Mingshe Zhu (BMS)
|
Seminar luncheon
|
10/7/2011
|
845 - 1730
|
SF Bay Area: Foster City Crowne Plaza
|
The Drug Discovery and Development Process for Scientists: Overview, Practices, and Case Studies
|
(1)SRI International
|
Michael W. Dong, Lesley Murray, Bruce Roth, Premal Patel (Genentech)
|
Workshop
|
9/16/2011
|
1100 - 1330
|
SF Bay Area: Foster City Crowne Plaza
|
QT prolongation and Thorough QT study for cardiac safety – What a drug developer should know
|
(1)CoreLab Partners Inc
|
Peter Staehr, MD (Theravance)
|
Seminar luncheon
|
8/29/2011
|
845 - 1700
|
SF Bay Area: Foster City Crowne Plaza
|
Preclinical development & IND Filing: Nuts, Bolts, and Best Practices
|
(1)Formurex, Inc.
|
Cuiping “Tracy” Chen (Depomed), Bert Ho (ChemoCentryx), Linval Depass (Duret), Jim Wei (Medpace)
|
Workshop
|
8/26/2011
|
1100 - 1330
|
San Diego Area: Embassy Suites La Jolla
|
Clinical Development of Peptide Therapeutics
|
(1)Beckman Coulter
|
Chris Rhodes (ex-Amylin)
|
Seminar luncheon
|
6/15/2011
|
1100 - 1330
|
Embassy Suites: La Jolla
|
Low-Flow LC/MS/MS for Quantitative Bioanalysis in a Discovery DMPK Laboratory
|
(1)Optivia Biotechnology
|
Heather Skor (Pifzer), Ravi Rahavendran (Pfizer)
|
Seminar luncheon
|
6/13/2011
|
845 - 1730
|
Bay Area: Foster City Crowne Plaza
|
CMC Strategies for Robust Product Development & NDA submissions
|
|
Ram Nyshadham, Raj Suryanarayan, Vijay Sabesan, David Shields, Sri Mudumba
|
Workshop
|
5/23/2011
|
1245 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Species Differences in Metabolism, Transporters and Pharmacokinetics
|
(1)Simulations Plus, Inc.
|
Mary Paine (UNC-chapel Hill), Erica Woodahl (Univ. of Montana), Steven Wrighton (Consultant), Maciej Zamek-Gliszczynski (Eli Lilly)
|
Workshop
|
5/20/2011
|
1100 - 1330
|
Bay Area: Foster City Crowne Plaza
|
Biosimilars: Science, Business, IP, and Regulatory considerations
|
(1)Shimadzu Scientific Instruments, Inc
|
Deborah Fishman (Dickstein Shapiro LLP), Jen Liu (Orrick)
|
Seminar luncheon
|
4/26/2011
|
845 - 1730
|
San Diego: La Jolla Embassy Suites
|
Dried Blood Spots for Bioanalysis – A Microsampling Approach for Preclinical and Clinical PK/TK Studies
|
(1)Alturas Analytics
|
Christopher Evans, Alan Stokes (GSK), Qin Ji (BMS)
|
Workshop
|
4/25/2011
|
845 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Dried Blood Spots for Bioanalysis – A Microsampling Approach for Preclinical and Clinical PK/TK Studies
|
(1)Alturas Analytics
|
Christopher Evans, Alan Stokes (GSK), Qin Ji (BMS)
|
Workshop
|
2/25/2011
|
1100 - 1330
|
Bay Area: Foster City Crowne Plaza
|
Pharmaceutical Excipients – Adding Functionality to Product Development (Jointly with AAPS-BADG)
|
(1)AAIPharma
|
Raju Gadiraju (Nektar Therapeutics)
|
Seminar luncheon
|
2/18/2011
|
1100 - 1330
|
San Diego: La Jolla Embassy Suites
|
AMS: A Smarter Way to Cut Through MIST?
|
(1)Vitalea Science
|
Robert Inggs, PhD (RMI Pharmocokinetics)
|
Seminar luncheon
|
1/12/2011
|
845 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Interpretation of CID Mass Spectra Level II (by Professor Henion)
|
|
Professor Jack Henion
|
Workshop
|
1/11/2011
|
845 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Interpretation of CID Mass Spectra Level I (by Professor Henion)
|
|
Professor Jack Henion
|
Workshop
|
12/10/2010
|
1100 - 1330
|
Bay Area: Foster City Crowne Plaza
|
Metabolomics as a Unique Biochemical Approach for Therapeutic Discovery
|
|
Prof. Gary Siuzdak (Scripps Research Institute)
|
Seminar luncheon
|
12/8/2010
|
1245 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Preclinical radiolabelled mass balance and metabolite profiling studies
|
(1)ABC Laboratories
|
Bernard Murray (Gilead), Ron Aoyama (Cytokinetics), Matthew Wright (Gilead), Radiochemist name TBD
|
Workshop
|
12/3/2010
|
1100 - 1330
|
Embassy Suites: La Jolla
|
Site-specific labeling of proteins with NMR-active unnatural amino acids
|
|
Bernhard Geierstanger
|
Seminar luncheon
|
11/5/2010
|
1245 - 1730
|
Embassy Suites: La Jolla
|
Principles of PK-PD with applications to small molecules and biopharmaceuticals: A guided tour for the non-expert
|
|
Kenneth Luu (Pfizer), Paolo Vicini (Pfizer)
|
Workshop
|
11/4/2010
|
1245 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Hiogh Clearance and Poor Bioavailability: Case Studies on identifying & solving the problems
|
(1)Absorption Systems
|
Marcel Hop (Genentech), Verne Cowles (Depomed), Chris Yang (Gilead), Simon Wong (Amgen)
|
Workshop
|
10/1/2010
|
1100 - 1330
|
Bay Area: Foster City Crowne Plaza
|
Utility of nanowire technology in oral drug delivery
|
|
Professor Tejle Desai, UCSF
|
Seminar luncheon
|
9/14/2010
|
845 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Pharmacokinetics Course for industrial scientists II: human PK prediction
|
(1)Optivia Biotechnology
|
Jiunn Lin (ex-Merck Executive Director)
|
Workshop
|
9/13/2010
|
845 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Pharmacokinetics Course for industrial scientists I: the principles of pharmacokinetics and its role in drug absorption, distribution, metabolism and excretion
|
(1)SRI International
|
Jiunn Lin (ex-Merck Executive Director)
|
Workshop
|
9/10/2010
|
1100 - 1330
|
Embassy Suites: La Jolla
|
Metabolomics as a Unique Biochemical Approach for Therapeutic Discovery
|
(1)Agilent
|
Prof. Gary Siuzdak (Scripps Research Institute)
|
Seminar luncheon
|
8/2/2010
|
1245 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Pharmacokinetic Modeling: Simulation Platforms for In Vitro–In Vivo extrapolation (IVIVE) and Physiological Based Pharmacokinetic (PBPK) Modeling
|
(1)BD Biosciences
|
Harvey Wong (Genentech); Matt Wright (Gilead); Natilie Hosea (Pfizer); Jane Kenny (Genentech)
|
Workshop
|
6/18/2010
|
1100 - 1330
|
Embassy Suites: La Jolla
|
Solving Critical ADME/PK Issues in Drug Discovery and Development
|
(1)Absorption Systems
|
Weichao Chen, Ph.D. (Arena)
|
Seminar luncheon
|
6/10/2010
|
845 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Solid Oral Dosage Forms: Theory, Formulation Strategies & Case Studies for clinical developments (Full-day; Jointly with U of P)
|
(1)Pharmatek Laboratories, Inc.
|
B.R. Jasti, X. Li, R. Nyshadham, R. Mahalingam
|
Workshop
|
5/21/2010
|
1100 - 1330
|
Bay Area: Foster City Crowne Plaza
|
Ligand-Binding Mass Spectrometry to Investigate Protein Drug Biotransformation, Direct Candidate Selection, and Corroborate Immunoassays
|
|
Michael Hall, Ph.D. (Amgen)
|
Seminar luncheon
|
5/14/2010
|
1245 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Modern NMR technologies for trace compound analysis: metabolites, impurities, and degradants
|
|
J. Pease (Roche), R. Subramanian (Amgen), S.Khera (AMgen), et al.
|
Workshop
|
4/20/2010
|
1245 - 1730
|
San Diego: Del Mar Marriot
|
Drug Transporters: Interpretation and Application of the International Transporter Consortium Whitepaper and Draft FDA Guidance
|
(1)Optivia Biotechnology
|
Joseph Polli (GSK), Caroline Lee (Pfizer), Harma Ellens (GSK), Xiaoyan Chu (Merck)
|
Workshop
|
4/19/2010
|
1245 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Drug Transporters: Interpretation and Application of the International Transporter Consortium Whitepaper and Draft FDA Guidance
|
(1)Qualyst, Inc.
|
Joseph Polli (GSK), Caroline Lee (Pfizer), Harma Ellens (GSK), Xiaoyan Chu (Merck)
|
Workshop
|
3/12/2010
|
1100 - 1330
|
San Diego: Embassy Suites-La Jolla
|
The Application of Dried Blood Spots for Quantitation of Xenobiotics - Pre-Clinical DMPK New Directions
|
(1)Alturas Analytics, Inc.
|
Chester Bowen
|
Seminar luncheon
|
3/10/2010
|
1245 - 1730
|
Bay Area: Foster City Crowne Plaza
|
ADME Sciences as Applied to Assessing Safety Testing (MIST)
|
|
Scott Obach (Pfizer)
|
Workshop
|
2/22/2010
|
1245 - 1730
|
Bay Area: Foster City Crowne Plaza
|
Preclinical Toxicology and drug safety: large molecules
|
(1)Pacific BioLabs
|
Ben Marafino, Kathleen Meyer
|
Workshop
|
2/19/2010
|
1100 - 1330
|
Bay Area: Foster City Crowne Plaza
|
Towards a Standardized Metabolomics Repository (Jointly with Bay Area Bioinformatics Forum)
|
|
Professor Oliver Fiehn, UC Davis
|
Seminar luncheon
|
1/20/2010
|
1800 - 2100
|
Bay Area: Crowne Plaza Foster City
|
Poorly Soluble Drugs: Pharmaceutical Development Strategies and Approaches for Pre Clinical Applications (jointly with AAPS-BADG)
|
(1)Formurex, Inc.
|
K. Nagapudi, S. Nadkarni, S. Neeravannan
|
Dinner Seminar
|
| < > |